A detailed history of American Portfolios Advisors transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, American Portfolios Advisors holds 100 shares of ANIP stock, worth $5,636. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$5,636
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$29.83 - $38.01 $2,983 - $3,801
100 New
100 $3.21 Million
Q3 2021

Mar 22, 2023

BUY
$26.48 - $35.99 $2,648 - $3,599
100 Added 100.0%
200 $6.56 Million
Q2 2021

Mar 22, 2023

BUY
$31.86 - $38.6 $3,186 - $3,860
100 Added 100.0%
200 $7.01 Million
Q1 2021

Mar 22, 2023

BUY
$28.4 - $36.14 $2,840 - $3,614
100 Added 100.0%
200 $7.23 Million
Q4 2020

Mar 22, 2023

BUY
$23.69 - $31.47 $2,369 - $3,147
100 Added 100.0%
200 $5.81 Million
Q3 2020

Mar 22, 2023

BUY
$26.38 - $33.1 $2,638 - $3,310
100 Added 100.0%
200 $5.64 Million
Q2 2018

Mar 24, 2023

SELL
$56.38 - $68.08 $5,638 - $6,808
-100 Closed
0 $0

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.